Skip to main content
. 2020 Oct 6;29(12):1755–1762. doi: 10.1007/s10068-020-00829-0

Table 2.

Objective sleep parameters analyzed by EEG after the intake of onion extract and placebo conditions

Evaluated factor Onion extract (n = 21) Placebo (n = 21)
Total sleep time Min 335.4 ± 9.0 323.4 ± 8.8
Sleep period time Min 375.5 ± 11.1 358.1 ± 10.1
During REM sleep latency Min 68.5 ± 4.2 66.7 ± 3.0
Sleep latency Min 27.3 ± 5.4 38.8 ± 10.0

Total time of NREM sleep stage 1

(ratio of NREM sleep stage 1)

Min

(%)

56.9

(15.0)

±

4.3

(0.9)

53.9

(15.2)

±

3.7

(1.1)

Total time of NREM sleep stage 2

(ratio of NREM sleep stage 2)

Min

(%)

181.0

(48.5)

±

5.5

(1.0)

173.2

(48.3)

±

6.9

(1.4)

Total time of NREM sleep stage 3

(ratio of NREM sleep stage 3)

Min

(%)

14.9

(4.1)

±

3.0

(0.8)

13.5

(3.8)

±

3.0

(0.8)

Total time of NREM sleep stage 1–3

(ratio of NREM sleep stage 1–3)

Min

(%)

252.8

(67.6)

±

6.8

(0.8)

240.6

(67.3)

±

6.0

(0.8)

Total time of REM sleep

(ratio of REM sleep)

Min

(%)

82.5

(22.0)

±

3.7

(0.8)

82.9

(23.1)

±

3.9

(0.8)

Awakening index Times 12.5 ± 0.9 11.5 ± 0.9
Wake after sleep onset (WASO) Min 40.1 ± 3.8 34.7 ± 3.1
Sleep efficiency % 82.4 ± 1.7 81.3 ± 2.0
Delta power during first NREM µV2 100710.6 ± 9489.2 89714.3 ± 9187.7
Delta power during first NREM/min µV2/min 1599.0 ± 124.5* 1454.8 ± 132.4
Delta power during NREM µV2 286900.5 ± 30073.3* 252816.1 ± 21997.3
Delta power during NREM/min µV2/min 1134.9 ± 109.2 1056.0 ± 91.0

EEG: electroencephalogram, REM: rapid-eye movement, NREM: non-rapid eye movement

All values are expressed as mean ± SE. *Intergroup comparison (p < 0.05, vs. placebo group)